MT10 Higher SARS-CoV-2 Spike Antibody Levels Are Associated With Reduced Risk of Subsequent Symptomatic and Severe COVID-19: A Real-World Data Study
Jun 1, 2024, 00:00 AM
10.1016/j.jval.2024.03.1548
https://www.valueinhealthjournal.com/article/S1098-3015(24)01663-2/fulltext
Section Title :
Section Order :
10932
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(24)01663-2&doi=10.1016/j.jval.2024.03.1548